We’ve all seen and used the American College of Cardiology 10-year atherosclerotic cardiovascular disease (ASCVD) risk calculator. There are several modifiable risk factors such as blood pressure, cholesterol, and smoking status that, if addressed, can lower ASCVD risk. But are there other modifiable risk factors that we are failing to account for and might be able to address? New evidence suggests systemic inflammation may be one.
Guest Authors: Ian Hatlee, Pharm.D and Scott Pearson, Pharm.D.
Music by Good Talk
On the Look Out for Prescribing Cascades
Thiazides in Chronic Kidney Disease: New Evidence Challenging Old Dogma
Sequential Additions or Multicomponent Combination? Should Our Approach to Hypertension Be Re-examined?
Extra Protection? Finerenone Use in Patients with Type 2 DM and CKD
Assessing HER Acceptability of Contraception
Preserving hope for patients with Heart Failure with Preserved Ejection Fraction (HFpEF)?
Top Ten Things Every Clinician Should Know about Continuous Glucose Monitors (CGM)
Spice Up Your Sleep Life with Saffron
Will a Dual GIP/GLP-1 Receptor Agonist SURPASS the Crowd?
Cut It Out! Removing EHR Allergy Warnings to Improve Antimicrobial Stewardship
What’s the Right Dose of Aspirin in Patients with Heart Disease?
Bursting the Steroid Bubble: Short-term Use Has Its Consequences
Guiding Antiplatelet Therapy: Is a Personalized Approach Worth It?
Psilocybin for Depression: Is it Worth the Trip?
Up the Creek Without a Paddle? Look to Your Pharmacist to Bridge-It
SGLT2i plus MRAs for Heart Failure: A Sweet or Sour Combination?
Is As-Needed Nasal Corticosteroid Use Needed for Allergic Rhinitis Management?
STEP-ping Up the Game for Weight Management
Raised From The Grave: A Second Life for Sotagliflozin?
Tiny (n-of-1) Trials to Overcome Statin-Associated Muscle Pain
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive